RBF Capital LLC raised its holdings in shares of MultiPlan Co. (NYSE:MPLN - Free Report) by 62.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 147,051 shares of the company's stock after acquiring an additional 56,470 shares during the quarter. RBF Capital LLC owned approximately 0.91% of MultiPlan worth $2,173,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Prudential Financial Inc. purchased a new position in shares of MultiPlan during the 4th quarter worth approximately $2,494,000. Trexquant Investment LP acquired a new stake in MultiPlan during the 4th quarter valued at $610,000. Beach Point Capital Management LP grew its holdings in MultiPlan by 9.2% during the 4th quarter. Beach Point Capital Management LP now owns 384,982 shares of the company's stock valued at $5,690,000 after buying an additional 32,582 shares during the last quarter. Walleye Capital LLC acquired a new position in shares of MultiPlan in the fourth quarter worth $359,000. Finally, Oppenheimer & Co. Inc. acquired a new position in shares of MultiPlan in the fourth quarter worth $292,000. Institutional investors and hedge funds own 87.15% of the company's stock.
MultiPlan Stock Down 2.5 %
Shares of NYSE MPLN opened at $19.57 on Wednesday. The firm has a market cap of $316.47 million, a P/E ratio of -0.21 and a beta of 0.13. The company has a debt-to-equity ratio of 21.73, a quick ratio of 1.05 and a current ratio of 1.05. MultiPlan Co. has a 1 year low of $4.80 and a 1 year high of $31.01. The firm's 50 day moving average price is $21.49 and its 200 day moving average price is $15.11.
Analyst Ratings Changes
Separately, Citigroup increased their price objective on MultiPlan from $10.00 to $12.50 and gave the company a "neutral" rating in a research note on Friday, January 10th.
Read Our Latest Stock Analysis on MultiPlan
MultiPlan Profile
(
Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
